Compare LI & STE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LI | STE |
|---|---|---|
| Founded | 2015 | 1985 |
| Country | China | United States |
| Employees | N/A | 3700 |
| Industry | Auto Manufacturing | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.5B | 21.3B |
| IPO Year | 2019 | 2018 |
| Metric | LI | STE |
|---|---|---|
| Price | $10.87 | $212.51 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 26 | 9 |
| Target Price | $15.65 | ★ $263.13 |
| AVG Volume (30 Days) | ★ 2.8M | 557.4K |
| Earning Date | 11-25-2026 | 11-04-2026 |
| Dividend Yield | N/A | ★ 1.32% |
| EPS Growth | N/A | ★ 27.90 |
| EPS | N/A | ★ 7.93 |
| Revenue | N/A | ★ $5,935,900,000.00 |
| Revenue This Year | N/A | $7.35 |
| Revenue Next Year | $25.64 | $6.36 |
| P/E Ratio | $29.50 | ★ $26.40 |
| Revenue Growth | N/A | ★ 8.73 |
| 52 Week Low | $11.09 | $195.14 |
| 52 Week High | $24.89 | $269.44 |
| Indicator | LI | STE |
|---|---|---|
| Relative Strength Index (RSI) | 35.25 | 44.05 |
| Support Level | N/A | $208.29 |
| Resistance Level | $12.56 | $220.39 |
| Average True Range (ATR) | 0.25 | 3.60 |
| MACD | -0.06 | 0.73 |
| Stochastic Oscillator | 9.24 | 84.54 |
Li Auto is one of China's leading new energy vehicle manufacturers. Founded in 2015, the company designs, develops, manufactures, and sells premium smart NEVs with a particular focus on family size premium SUVs and MPVs. Li Auto started volume production of its first model—the Li One, an SUV that is a premium plug-in electric vehicle- in November 2019. Besides PHEVs, its product portfolio now extends to EVs that are fully battery-powered, reaching a wide audience. It has sold over 400,000 NEVs in 2025, accounting for about 3% of China's passenger NEV market.
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 20% from Applied Sterilization Technologies, or AST, and 10% from life sciences services after the divestment of its dental products business.